The University of North Carolina at Chapel Hill
Skip to main content
UNC School of Medicine
Make a Gift

Latest Posts

BRC Investigators Publish Results of Randomized Trial of Anti-Fibrinolytic Therapy and Ancillary Laboratory Study in ‘Blood’ and ‘Blood Advances’

September 19, 2022
In the NIH-funded ‘American Trial Using Tranexamic Acid in Thrombocytopenia (A-TREAT)’ trial, UNC was one of 3 participating clinical centers to enroll patients with platelet transfusion-dependence due to therapy for hematologic malignancies. Between 2016 and 2020, 337 patients were randomized in a double blind fashion to tranexamic acid (TXA) or...

Matt Flick, Ph.D. Awarded NIH U01 Grant

August 20, 2022
Matthew Flick, PhD was recently awarded a NIH U01 grant, which is part of the Pancreatic Ductal Adenocarcinoma (PDAC) Stromal Reprogramming Consortium (PSRC). This is an MPI award that Dr. Flick received with collaborators Bumsoo Han, PhD at Purdue University and Melissa Fishel, PhD at the Indiana University School of...

Raj Kasthuri, MD and Yara Park, MD Published in Blood, “Race, Rituximab, and Relapse in TTP”

July 28, 2022
  Drs. Raj Kasthuri and Yara Park of the UNC BRC, along with multiple alumni of the UNC hematology and transfusion medicine fellowships, co-authored a multi-institutional investigation into the role of race in the response of TTP patients to rituximab that has been accepted for publication in Blood. The study...

Matt Karafin, MD is a Collaborating Investigator on a Recently Awarded Multi-Institution R21 Grant From the NIH-NHBLI

July 26, 2022
The focus of the grant is to investigate red blood cell alloimmunization risk using the REDS-III databases. Red blood cell (RBC) alloimmunization is a leading cause of morbidity and mortality in transfusion and pregnancy settings, resulting in hemolytic reactions and other adverse sequelae such as hemolytic disease of the fetus...

Patrick Ellsworth, MD Awarded Research Grant

July 22, 2022
Dr. Patrick Ellsworth has been awarded the Access to Insight 2022 Basic Research Grant, totaling 63,000 Euros! This was a competitive grant with international applicants. Dr. Ellsworth’s project is titled “Mechanistic Investigation of Factor IX/IXa Synergy with Emicizumab” and he will be working with Dr. Monroe here of the BRC and...

Alisa Wolberg, PhD New Chair of HTBT Study Section

July 22, 2022
Effective July 1, 2022, Dr. Alisa Wolberg began service as the new Chair of the Hemostasis, Thrombosis, Blood Cells, and Transfusion study section of the NHLBI. She will serve a 2-year term in this role. Congratulations, Dr. Wolberg!

UNC Contribution to Gene Therapy in Hemophilia Highlighted by Endeavors Magazine

June 16, 2022
“A gene therapy clinical trial for hemophilia shows promise and could be approved by the FDA later this year — a feat made possible, in part, by UNC-Chapel Hill’s 70-year-old research program.” Click here to read the article.

BRC Newsletter – June 2022

June 3, 2022
Click here to read the June 2022 Newsletter

Abigail Ballard, GS

May 31, 2022
Bergmeier Lab Department of Biochemistry and Biophysics

Ada Chang

May 31, 2022
Lab: Jane Little Department: School of Medicine – Hematology

Ananya Dutta, PhD

May 31, 2022
Flick Lab Pathology and Laboratory Medicine

Chatphatai Moonla, MD, MSc

May 31, 2022
Key Lab Department of Medicine, Division of Hematology